Loading...

A Phase 1, Open-Label, Randomized, 5-Way Crossover Study to Compare the Bioavailability, Pharmacokinetics, and Safety of Febuxostat After Single Oral Doses of Febuxostat 80 mg Immediate Release Tablet and Multiparticulate 80 mg Capsule Formulations - Vivli | NLM Dataset Catalog